(Q38047203)

27 August 2017

title

Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation (English)

1 reference

27 August 2017

main subject

organ transplantation

1 reference

1 reference

1 reference

4

1 reference

27 August 2017

Troels K Bergmann

1

1 reference

27 August 2017

Katherine A Barraclough

series ordinal

2

1 reference

27 August 2017

Katie J Lee

series ordinal

3

1 reference

27 August 2017

publication date

1 November 2012

1 reference

Clinical Pharmacokinetics

27 August 2017

published in

1 reference

27 August 2017

volume

51

1 reference

27 August 2017

issue

11

1 reference

27 August 2017

page(s)

711-741

1 reference

Clinical Pharmacokinetics of Prednisone and Prednisolone

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Impaired conversion of prednisone to prednisolone in patients with liver cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Clinical pharmacokinetics of prednisone and prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Metabolism of synthetic steroids by the human placenta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

A pharmacokinetic/pharmacodynamic approach to predict total prednisolone concentrations in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Biowaiver monographs for immediate release solid oral dosage forms: prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Dose dependent pharmacokinetics of prednisone and prednisolone in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prednisolone pharmacokinetics in the presence and absence of ritonavir after oral prednisone administration to healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

The dose-dependent systemic availability of prednisone: one reason for the reduced biological effect of alternate-day prednisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Nonlinear plasma protein binding and haemodialysis clearance of prednisolone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prednisone metabolism in recipients of kidney or liver transplants and in lung recipients receiving ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Area-under-the-curve monitoring of prednisolone for dose optimization in a stable renal transplant population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Oral prednisone for chronic active liver disease: dose responses and bioavailability studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prednisone or prednisolone for the treatment of chronic active hepatitis? A comparison of plasma availability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Corticosteroids in liver disease: Studies on the biological conversion of prednisone to prednisolone and plasma protein binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Differences in metabolic properties among cortisol, prednisolone, and dexamethasone in liver and renal diseases: accelerated metabolism of dexamethasone in renal failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prednisolone protein binding in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Pharmacokinetic determinants of cyclosporine and prednisone in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Changes in plasma protein binding have little clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Pharmacokinetics of prednisone and its metabolite prednisolone in children with nephrotic syndrome during the active phase and in remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prednisolone disposition in steroid-dependent asthmatic children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Alterations in prednisolone disposition as a result of time of administration, gender and dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prednisolone absorption in acute colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Absorption of prednisolone in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Pharmacokinetics of prednisone and prednisolone in a case of hypothyroidism: effect of replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Structural determinants of P-glycoprotein-mediated transport of glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Decrease in oral bioavailability of ciclosporin by intravenous pulse of methylprednisolone succinate in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Effect of age, ethnicity, and glucocorticoid use on tacrolimus pharmacokinetics in pediatric renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Pharmacokinetic interaction between corticosteroids and tacrolimus after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Tacrolimus pharmacokinetic drug interactions: effect of prednisone, mycophenolic acid or sirolimus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Therapeutic drug monitoring of sirolimus: effect of concomitant immunosuppressive therapy and optimization of drug dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Tissue effects of glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Mechanisms of Glucocorticoid Action on Immune Processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Molecular mechanisms of glucocorticoid action: what is important?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Nongenomically initiated steroid actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Population pharmacokinetic/pharmacodynamic modeling of systemic corticosteroid inhibition of whole blood lymphocytes: modeling interoccasion pharmacodynamic variability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Factors that influence clinical responses to administered corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prevalence and causes of low bone density and fractures in kidney transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Long-term follow-up of bone mass after orthotopic liver transplantation: effect of steroid withdrawal from the immunosuppressive regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prednisone-free maintenance immunosuppression-a 5-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Clinical practice. Glucocorticoid-induced bone disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prevention of fractures after solid organ transplantation: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Risk factors for nontraumatic osteonecrosis of the femoral head after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Renal transplantation without steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Determinants of short-term changes in body composition following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Benefits derivated from late steroid withdrawal in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Metabolic findings after liver transplantation within a randomised trial with or without steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prednisone withdrawal in kidney transplant recipients on cyclosporine and mycophenolate mofetil--a prospective randomized study. Steroid Withdrawal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Lack of radiological and clinical benefit over two years of low dose prednisolone for rheumatoid arthritis: results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

A systematic review on steroid withdrawal between 3 and 6 months after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Steroid-free immunosuppression since 1999: 129 pediatric renal transplants with sustained graft and patient benefits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Glucocorticoids and the risk for initiation of hypoglycemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Insulin resistance after renal transplantation: impact of immunosuppressive and antihypertensive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Glucose tolerance before and after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Risk factors for and management of post-transplantation cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Corticosteroids: do they damage the cardiovascular system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Polymorphisms in glutathione S-transferases and non-melanoma skin cancer risk in Australian renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Corticosteroid-induced cataracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

A randomized trial to assess the impact of early steroid withdrawal on growth in pediatric renal transplantation: the TWIST study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Preliminary analysis of early outcomes of a prospective, randomized trial of complete steroid avoidance in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Steroid withdrawal increases risk of acute rejection but reduces infection: a meta-analysis of 1681 cases in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Beneficial outcomes of a steroid-free regimen with thymoglobulin induction in pancreas-kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Minimizing steroid use in pediatric kidney recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Effects of steroid avoidance and novel protocols on growth in paediatric renal transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Corticosteroid avoidance in pediatric renal transplantation: can it be achieved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

KDIGO clinical practice guideline for the care of kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Effect of plasma lipid on pharmacokinetics of ciclosporin and its relationship with plasma prednisolone level in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Role of prednisolone pharmacokinetics in postchallenge glycemia after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

The expression of CYP2B6, CYP2C9 and CYP3A4 genes: a tangle of networks of nuclear and steroid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Genetic profiling defines the xenobiotic gene network controlled by the nuclear receptor pregnane X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Inter-individual difference determinant of prednisolone pharmacokinetics for Japanese renal transplant recipients in the maintenance stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

The MDR1 polymorphisms at exons 21 and 26 predict steroid weaning in pediatric heart transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

ABCB1 C3435T and G2677T/A polymorphism decreased the risk for steroid-induced osteonecrosis of the femoral head after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Twice daily fractionated dose administration of prednisolone compared to standard once daily administration to patients with glomerulonephritis or with kidney transplants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Growth rate in children receiving alternate-day corticosteroid treatment after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Steroid and calcineurin inhibitor-sparing protocols in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Steroid avoidance in renal transplantation using basiliximab induction, cyclosporine-based immunosuppression and protocol biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Multicenter randomized prospective trial of steroid withdrawal in renal transplant recipients receiving basiliximab, cyclosporine microemulsion and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

A randomized trial of steroid avoidance in renal transplant patients treated with everolimus and cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

KHA-CARI guideline: KHA-CARI adaptation of the KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Aggressive steroid weaning after cardiac transplantation is possible without the additional risk of significant rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Heart Transplant Report--2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Immunosuppressive therapy after human lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Impact of steroids on hepatitis C virus replication in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Early steroid-free immunosuppression with FK506 after liver transplantation: long-term results of a prospectively randomized double-blinded trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Corticosteroid avoidance in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Rapid discontinuation of corticosteroids in pediatric renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Extended experience with a steroid minimization immunosuppression protocol in pediatric renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Continued superior outcomes with modification and lengthened follow-up of a steroid-avoidance pilot with extended daclizumab induction in pediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Prospective, randomized trial on late steroid withdrawal in pediatric renal transplant recipients under cyclosporine microemulsion and mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Improved growth and cardiovascular risk after late steroid withdrawal: 2-year results of a prospective, randomised trial in paediatric renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Long-term follow-up of pediatric cardiac transplant recipients on a steroid-free regime: the role of endomyocardial biopsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Pediatric cardiac transplant: results using a steroid-free maintenance regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Safety and early outcomes using a corticosteroid-avoidance immunosuppression protocol in pediatric heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Measurement of cortisol, cortisone, prednisolone, dexamethasone and 11-deoxycortisol with ultra high performance liquid chromatography-tandem mass spectrometry: Application for plasma, plasma ultrafiltrate, urine and saliva in a routine laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Development of a sensitive and selective method for the quantitative analysis of cortisol, cortisone, prednisolone and prednisone in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Quantitative, highly sensitive liquid chromatography-tandem mass spectrometry method for detection of synthetic corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

No impact of age on dose-adjusted pharmacokinetics of tacrolimus, mycophenolic acid and prednisolone 1 month after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Glucocorticoid pharmacokinetics and growth retardation in children with renal transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Concurrent administration of antacids and prednisone: effect on serum levels of prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

The effect of concurrent administration of antacids on prednisolone absorption [letter]

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Impact of ketoconazole on the metabolism of prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Adjunctive Therapy of Allergic Bronchopulmonary Aspergillosis with Itraconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Diltiazem retards the metabolism of oral prednisone with effects on T-cell markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Case of psychosis due to prednisone-clarithromycin interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Effect of Oral Administration of Glycyrrhizin on the Pharmacokinetics of Prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Alteration of plasma prednisolone levels by indomethacin and naproxen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Influence of antiretroviral drugs on the pharmacokinetics of prednisolone in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40262-012-0007-8

Effect of liver function on the metabolism of prednisone and prednisolone in humans

21 January 2018

1 reference

12 December 2020

Steroid avoidance or withdrawal for kidney transplant recipients

1 reference

12 December 2020

The influence of uremia on pharmacokinetics and protein binding of prednisolone

1 reference

12 December 2020

Bioavailability of prednisolone in patients with intestinal malabsorption: the importance of measuring serum protein-binding

1 reference

12 December 2020

Bone mineral density in kidney transplant recipients and patients on hemodialysis: a comparison with healthy individuals

1 reference

12 December 2020

Prednisolone disposition in obese men

1 reference

12 December 2020

Increase in tacrolimus trough levels after steroid withdrawal

1 reference

12 December 2020

Growth and endocrine function in children receiving long-term steroid therapy for renal disease

1 reference

12 December 2020

Renal transplantation in young children

1 reference

12 December 2020

1 reference

12 December 2020

Users of low-dose glucocorticoids have increased bone loss rates: A longitudinal study

1 reference

12 December 2020

Relationship between steroid dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging

1 reference

12 December 2020

Cyclosporin A drug interactions. Screening for inducers and inhibitors of cytochrome P-450 (cyclosporin A oxidase) in primary cultures of human hepatocytes and in liver microsomes.

1 reference

12 December 2020

Therapeutic drug monitoring of prednisolone after lung transplantation

1 reference

12 December 2020

Ocular complications in renal transplant patients

1 reference

12 December 2020

A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy

1 reference

12 December 2020

Corticosteroid interactions with cyclosporine, tacrolimus, mycophenolate, and sirolimus: fact or fiction?

1 reference

12 December 2020

Clinical results and cyclosporine effect on prednisolone metabolism of cadaver kidney transplanted patients

1 reference

12 December 2020

Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia

1 reference

12 December 2020

Relation between steroid dose, body composition and physical activity in renal transplant patients

1 reference

12 December 2020

Kinetics of prednisolone and endogenous cortisol suppression in the elderly

1 reference

12 December 2020

Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation

1 reference

12 December 2020

Bioavailability and reversible metabolism of prednisone and prednisolone in man

1 reference

12 December 2020

Altered prednisolone pharmacokinetics in patients with cystic fibrosis

1 reference

12 December 2020

The effect of cyclosporine on the pharmacokinetics of prednisolone in renal transplant patients

1 reference

12 December 2020

Prednisolone pharmacodynamics: leukocyte trafficking in the rat

1 reference

12 December 2020

Triple-drug immunosuppression with steroid discontinuation by six months after heart transplantation

1 reference

12 December 2020

Urinary 6 beta-hydroxyprednisolone excretion indicates enhanced prednisolone catabolism

1 reference

12 December 2020

Prednisone side-effects and serum-protein levels. A collaborative study

1 reference

12 December 2020

Serum prednisolone levels in Crohn's disease and coeliac disease following oral prednisolone administration

1 reference

12 December 2020

Pharmacokinetics and protein binding of prednisolone in patients with nephrotic syndrome and patients undergoing hemodialysis

1 reference

12 December 2020

Prednisolone disposition in cushingoid and noncushingoid kidney transplant patients

1 reference

12 December 2020

Ocular Changes in Renal Transplant Patients

1 reference

12 December 2020

Inhibition of prednisolone metabolism by cyclosporine in kidney-transplanted patients

1 reference

12 December 2020

Altered metabolism and decreased efficacy of prednisolone and prednisone in patients with hyperthyroidism

1 reference

12 December 2020

Prednisolone disposition and protein binding in oral contraceptive users

1 reference

12 December 2020

Randomized controlled trial of steroids versus no steroids in stable cyclosporine-treated renal graft recipients

1 reference

12 December 2020

Modified elimination of prednisolone in epileptic patients on carbamazepine monotherapy, and in women using low-dose oral contraceptives

1 reference

12 December 2020

Necrosis of the femoral head after kidney transplantation

1 reference

12 December 2020

Evidence that cyclosporine does not affect the metabolism of prednisolone after renal transplantation

1 reference

12 December 2020

Downregulation of hepatic cytochrome P450 in chronic renal failure.

1 reference

12 December 2020

Prednisolone pharmacokinetics in cushingoid and non-cushingoid kidney transplant patients

1 reference

12 December 2020

Case of mania due to prednisone-clarithromycin interaction

1 reference

12 December 2020

Long-term (24-month) follow-up of steroid withdrawal in renal allograft recipients with posttransplant diabetes mellitus

1 reference

12 December 2020

Pharmacokinetics of 3 prednisolone prodrugs. Evidence of therapeutic inequivalence in renal transplant patients with rejection

1 reference

12 December 2020

Prednisolone and methylprednisolone kinetics in children receiving anticonvulsant therapy

1 reference

12 December 2020

Prednisone for chronic active liver disease: pharmacokinetics, including conversion to prednisolone

1 reference

12 December 2020

Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy

1 reference

12 December 2020

Corticosteroids do not alter the threshold for vertebral fracture

1 reference

12 December 2020

The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients

1 reference

12 December 2020

Selective late steroid withdrawal after renal transplantation

1 reference

12 December 2020

Thymoglobulin induction and steroid avoidance in cardiac transplantation: results of a prospective, randomized, controlled study.

1 reference

12 December 2020

Alternate-day steroids in children after renal transplantation

1 reference

12 December 2020

Effect of an oral contraceptive on the plasma levels of budesonide and prednisolone and the influence on plasma cortisol

1 reference

12 December 2020

The Absence of Effect of Azathioprine on Prednisolone Pharmacokinetics Following Maintenance Prednisone Doses in Kidney Transplant Patients

1 reference

12 December 2020

Pharmacokinetics of prednisolone and endogenous hydrocortisone levels in cushingoid and non-cushingoid patients

1 reference

12 December 2020

Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone

1 reference

12 December 2020

Marked alterations in dose-dependent prednisolone kinetics in women taking oral contraceptives

1 reference

12 December 2020

Pharmacokinetics of methylprednisolone and prednisolone after single and multiple oral administration

1 reference

12 December 2020

Effect of inflammatory bowel disease on absorption and disposition of prednisolone

1 reference

12 December 2020

The inhibitory effects of glycyrrhizin and glycyrrhetinic acid on the metabolism of cortisol and prednisolone--in vivo and in vitro studies

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of prednisolone after intravenous and oral administration

1 reference

12 December 2020

The Influence of Glucocorticoid Dose on Protein Catabolism After Renal Transplantation

1 reference

12 December 2020

Effect of Corticosteroids on Blood Salicylate Concentration

1 reference

12 December 2020

Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation

1 reference

12 December 2020

Comparison of hyperlipidemia in dialysis patients, renal transplant recipients, and steroid treated nonrenal patients

1 reference

12 December 2020

Decreased Clearance of Prednisolone, a Factor in the Development of Corticosteroid Side Effects

1 reference

12 December 2020

Impairment of prednisolone metabolism by cyclosporine treatment in renal graft recipients.

1 reference

12 December 2020

Successful withdrawal of corticosteroids in heart transplantation

1 reference

12 December 2020

Effects of steroid withdrawal on long-term renal allograft recipients with posttransplantation diabetes mellitus

1 reference

12 December 2020

A controlled trial of steroids in cyclosporine-treated renal transplant recipients

1 reference

12 December 2020

Association of the absence of steroid therapy with increased cyclosporine blood levels in renal transplant recipients

1 reference

12 December 2020

Decreased bioavailability of prednisone due to antacids in patients with chronic active liver disease and in healthy volunteers

1 reference

12 December 2020

Effects of cyclosporin on prednisolone metabolism

1 reference

12 December 2020

Monitoring prednisone and prednisolone.

1 reference

12 December 2020

Steroid avoidance in renal transplant patients maintained on a cyclosporine-based protocol.

1 reference

12 December 2020

Pharmacokinetics of methylprednisolone and rejection episodes in kidney transplant patients

1 reference

12 December 2020

Effects of low-dose prednisolone on cyclosporine pharmacokinetics in liver transplant recipients: radioimmunoassay with specific and non-specific monoclonal antibodies

1 reference

12 December 2020

The transplacental passage of prednisone and prednisolone in pregnancy near term

1 reference

12 December 2020

Effect of corticosteroids on the expression of cytochromes P450 and on cyclosporin A oxidase activity in primary cultures of human hepatocytes

1 reference

12 December 2020

Drug interaction--induced osteonecrosis of femoral head

1 reference

12 December 2020

Some Characteristics of Steroid Diabetes: A Study in Renal-Transplant Recipients Receiving High-Dose Corticosteroid Therapy

1 reference

12 December 2020

Ocular disorders in renal transplant patients

1 reference

12 December 2020

1 reference

12 December 2020

Pharmacokinetic characteristics of methylprednisolone in Korean renal transplant recipients

1 reference

12 December 2020

Prednisolone absorption in coeliac disease

1 reference

12 December 2020

Initial success of steroid weaning late after heart transplantation

1 reference

12 December 2020

Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients

1 reference

12 December 2020

Pharmacokinetics of prednisolone during administration of sirolimus in patients with renal transplants

1 reference

12 December 2020

1 reference

12 December 2020

The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids

1 reference

12 December 2020

Alternate day steroids and blood pressure control after renal transplantation

1 reference

12 December 2020

Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: a prospective, randomized, controlled study.

1 reference

12 December 2020

Evaluation of dose-related pharmacokinetics and pharmacodynamics of prednisolone in man

1 reference

12 December 2020

Studies on the expression and metabolic capabilities of human liver cytochrome P450IIIA5 (HLp3)

1 reference

12 December 2020

Clinical value of assessing prednisolone pharmacokinetics before and after renal transplantation

1 reference

12 December 2020

Alternate-day steroid dosing improves growth without adversely affecting graft survival or long-term graft function. A report of the North American Pediatric Renal Transplant Cooperative Study

1 reference

12 December 2020

Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies

1 reference

12 December 2020

Steroid withdrawal is safe and beneficial in stable cyclosporine-treated liver transplant patients

1 reference

12 December 2020

Interventions for preventing bone disease in kidney transplant recipients

1 reference

12 December 2020

New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression

1 reference

12 December 2020

Prednisolone metabolism and excretion in the isolated perfused rat kidney

1 reference

12 December 2020

Endogenous and exogenous glucocorticoids in cushingoid patients

1 reference

12 December 2020

Species- and gender-related differences in cyclosporine/prednisolone/sirolimus interactions in whole blood lymphocyte proliferation assays.

1 reference

12 December 2020

Simultaneous analysis of prednisone, prednisolone and their major hydroxylated metabolites in urine by high-performance liquid chromatography

1 reference

12 December 2020

ApoB C7623T polymorphism predicts risk for steroid-induced osteonecrosis of the femoral head after renal transplantation

1 reference

12 December 2020

Cyclosporine alone or in combination with prednisone in cadaveric renal transplantation

1 reference

12 December 2020

Prednisolone excretion in human milk

1 reference

12 December 2020

Prednisone and prednisolone bioavailability in renal transplant patients

1 reference

12 December 2020

Does early steroid withdrawal influence rejection and infection episodes during the first 2 years after heart transplantation?

1 reference

12 December 2020

Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation

1 reference

12 December 2020

Impairment of prednisolone disposition in patients with Graves' disease taking methimazole

1 reference

12 December 2020

Tacrolimus monotherapy without steroids after liver transplantation--a prospective randomized double-blinded placebo-controlled trial

1 reference

12 December 2020

The effect of itraconazole on the pharmacokinetics and pharmacodynamics of oral prednisolone

1 reference

12 December 2020

Double-blind comparison of two corticosteroid regimens plus mycophenolate mofetil and cyclosporine for prevention of acute renal allograft rejection

1 reference

12 December 2020

10.1007/S40262-012-0007-8

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1005227110

0 references

Fatcat ID

release_vxw7epnjrjhlzohaaqhr6zew2a

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/vxw7epnjrjhlzohaaqhr6zew2a

24 November 2022

mapped directly with Wikidata item

1 reference